Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
ABL Texcell Diagnostics said it signed a non-binding letter of intent to acquire 100% of Vela Diagnostics' activities in Singapore and the U.S. There will be no change in control or governance of ABL Texcell Diagnostics or Advanced Biological Laboratories.
ABL Texcell Diagnostics has signed a non-binding letter of intent to acquire 100% of Vela Operations Singapore and Vela Diagnostics USA. The company aims to consolidate an integrated international platform covering EMEA, Asia-Pacific, and the United States.